Paper Details

  1. Home
  2. Paper Details

Depot haloperidol decanoate for schizophrenia.

Author: DavidA, QuraishiS

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Antipsychotic medications are the primary treatment for schizophrenia. While oral medications are common, adherence can be a challenge. Depot injections, introduced in the 1960s, have become a widely used method for long-term management. Haloperidol decanoate is one such depot medication available for clinical use.
Paper Details　
Original Abstract of the Article :
The mainstay of treatment for schizophrenia is the antipsychotic group of drugs. These are usually given orally but compliance with medication given by this route may be difficult to quantify. Problems with treatment adherence are common. The development of depot injections in the 1960s gave rise to...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045751/

データ提供：米国国立医学図書館（NLM）

Depot Haloperidol Decanoate for Schizophrenia

Schizophrenia, a complex mental illness, can be like a desert mirage, making it difficult to distinguish reality from illusion. This study explores the use of haloperidol decanoate, a long-acting injection, in the management of schizophrenia. The authors discuss the challenges of medication adherence in schizophrenia and highlight the potential benefits of depot injections, which provide sustained medication levels over time.

Improving Treatment Adherence for Schizophrenia

The study underscores the importance of medication adherence in managing schizophrenia. Depot injections, like haloperidol decanoate, can provide a more consistent therapeutic effect by reducing the need for frequent medication administration.

A Tool for Managing Schizophrenia

Haloperidol decanoate, a long-acting injection, can be a valuable tool for managing schizophrenia by improving medication adherence and potentially leading to better treatment outcomes.

Dr.Camel's Conclusion

This study highlights the importance of innovative approaches to managing complex mental illnesses like schizophrenia. Depot injections can provide a valuable strategy for improving treatment outcomes by addressing the challenge of medication adherence.
Date :
  1. Date Completed 2000-07-06
  2. Date Revised 2023-11-13
Further Info :

Pubmed ID

10796438

DOI: Digital Object Identifier

PMC7045751

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.